NASD · Healthcare · Medical Devices · USA
SI-BONE Inc is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.
SI-BONE manufactures titanium implants and associated instruments for treating spinal and pelvic conditions, including sacroiliac joint problems, spine fusion procedures, and pelvic trauma. The company sells its products through a direct sales force in the United States and via direct sales, agents and resellers in other countries.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the SI-BONE Inc stock.
Overvalued: intrinsic value $8.16 per share, market price $23.16, margin of safety -183.8% (as of 2026-11-17).
A 1.6x revenue multiple, discounted for its losses, values the shares at $8.16; the price of $23.16 is 184% above that value.
17 more funds hold it; the full list is part of the paid plan.
All 140 Medical Devices stocks
43 more in this industry show a wider margin of safety.
SIBN is overvalued (as of the 2026-11-17 close). A 1.6x revenue multiple, discounted for its losses, values the shares at $8.16; the price of $23.16 is 184% above that value.
$8.16 per share (as of the 2026-11-17 close), against a market price of $23.16. That is a margin of safety of -183.8%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.